Malaria evolution in South Asia: Knowledge for control and elimination

Acta Tropica

Volumn 121, Issue 3, 2012, Pages 256-266

  Narayanasamy, Krishnamoorthy ^a   Chery, Laura ^b   Basu, Analabha ^c   Duraisingh, Manoj T ^d   Escalante, Ananias ^e   Fowble, Joseph ^b   Guler, Jennifer L ^b   Herricks, Thurston ^b   Kumar, Ashwani ^f   Majumder, Partha ^c   Maki, Jennifer ^b   Mascarenhas, Anjali ^b   Rodrigues, Janneth ^b   Roy, Bikram ^c   Sen, Somdutta ^a   Shastri, Jayanthi ^g,h   Smith, Joseph ⁱ   Valecha, Neena ^f   White, John ^b   Rathod, Pradipsinh K ^b  

^a Sphaera Pharma Research and Development   (India)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

^f NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^g Kasturba Hospital for Infectious Diseases   (India)

^h BYL NAIR CHARITABLE HOSPITAL   (India)

ⁱ SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Drug resistance; Epidemiology; ICEMR; India; Malaria; Plasmodium falciparum; Plasmodium vivax; South Asia

Indexed keywords

ARTEMISIN;

DISEASE CONTROL; DISEASE SPREAD; DRUG RESISTANCE; EPIDEMIOLOGY; MALARIA; MOSQUITO; PARASITE; PATHOGENICITY; RESEARCH;

ANOPHELES; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CELL INVASION; CLINICAL CLASSIFICATION; CLINICAL RESEARCH; DISEASE SEVERITY; DRUG TREATMENT FAILURE; EARLY DIAGNOSIS; ENDEMIC DISEASE; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE DEFORMABILITY; GENETIC TRAIT; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HOST PARASITE INTERACTION; HUMAN; INDIAN; INFECTION PREVENTION; INNATE IMMUNITY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MICROBIAL GENETICS; MOLECULAR EVOLUTION; MORTALITY; NONHUMAN; PARASITE TRANSMISSION; PARASITE VECTOR; PARASITE VIRULENCE; PLASMODIUM VIVAX MALARIA; PUBLIC-PRIVATE PARTNERSHIP; RESEARCH SUBJECT; RISK ASSESSMENT; SOUTH ASIA; URBAN RURAL DIFFERENCE; VECTOR CONTROL;

ANIMALS; COMMUNICABLE DISEASE CONTROL; CULICIDAE; GENETIC VARIATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOST-PARASITE INTERACTIONS; HUMANS; INDIA; INSECT VECTORS; INTERNATIONAL COOPERATION; MALARIA; MOSQUITO CONTROL; NATIONAL HEALTH PROGRAMS; PLASMODIUM; RESEARCH; SEVERITY OF ILLNESS INDEX;

INDIA;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 84862831616     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2012.01.008     Document Type: Article

References (131)

1. Abu-Zeid Y.A., Abdulhadi N.H., Theander T.G., Hviid L., Saeed B.O., Jepsen S., Jensen J.B., Bayoumi R.A. Seasonal changes in cell mediated immune responses to soluble Plasmodium falciparum antigens in children with haemoglobin AA and haemoglobin AS. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:20-22.
2. Acharya P., Pallavi R., Chandran S., Chakravarti H., Middha S., Acharya J., Kochar S., Kochar D., Subudhi A., Boopathi A.P., Garg S., Das A., Tatu U. A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin. Appl. 2009, 3:1314-1325.
3. Acharya P., Pallavi R., Chandran S., Dandavate V., Sayeed S.K., Rochani A., Acharya J., Middha S., Kochar S., Kochar D., Ghosh S.K., Tatu U. Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One 2011, 6:e26623.
4. Andersen P., Nielsen M.A., Resende M., Rask T.S., Dahlback M., Theander T., Lund O., Salanti A. Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog. 2008, 4:e42.
5. Avril M., Kulasekara B.R., Gose S.O., Rowe C., Dahlback M., Duffy P.E., Fried M., Salanti A., Misher L., Narum D.L., Smith J.D. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA. Infect. Immun. 2008, 76:1791-1800.
6. Awasthi G., Prasad G.B., Das A. Population genetic analyses of Plasmodium falciparum chloroquine receptor transporter gene haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India. Int. J. Parasitol. 2011, 41:705-709.
7. Balgir R.S. Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa. Indian J. Med. Sci. 2008, 62:362-371.
8. Baliga K.V., Uday Y., Sood V., Nagpal A. Acute febrile hepato-renal dysfunction in the tropics: co-infection of malaria and leptospirosis. J. Infect. Chemother. 2011, 17:694-697.
9. Bambardekar K., Dharmadhikari A.K., Dharmadhikari J.A., Mathur D., Sharma S. Measuring erythrocyte deformability with fluorescence, fluid forces, and optical trapping. J. Biomed. Opt. 2008, 13:064021.
10. Bulusu V., Jayaraman V., Balaram H. Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum. J. Biol. Chem. 2011, 286:9236-9245.
11. Beeson J.G., Rogerson S.J., Cooke B.M., Reeder J.C., Chai W., Lawson A.M., Molyneux M.E., Brown G.V. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat. Med. 2000, 6:86-90.
12. Beg M.A., Khan R., Baig S.M., Gulzar Z., Hussain R., Smego R.A. Cerebral involvement in benign tertian malaria. Am. J. Trop. Med. Hyg. 2002, 67:230-232.
13. Bockhorst J., Lu F., Janes J.H., Keebler J., Gamain B., Awadalla P., Su X.Z., Samudrala R., Jojic N., Smith J.D. Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. Mol. Biochem. Parasitol. 2007, 155:103-112.
14. Chitnis C.E., Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol. 2008, 24:29-34.
15. Choudhary V., Sharma Y.D. Extensive heterozygosity in flanking microsatellites of Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) gene among Indian isolates. Acta Trop. 2009, 109:241-244.
16. Chauhan V.S., Yazdani S.S., Gaur D. Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum. Hum. Vaccin. 2010, 6.
17. Cranston H.A., Boylan C.W., Carroll G.L., Sutera S.P., Williamson J.R., Gluzman I.Y., Krogstad D.J. Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science 1984, 223:400-403.
18. Crosnier C., Bustamante L.Y., Bartholdson S.J., Bei A.K., Theron M., Uchikawa M., Mboup S., Ndir O., Kwiatkowski D.P., Duraisingh M.T., Rayner J.C., Wright G.J. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011, 480:534-537.
19. Das Gupta R.K., Thakor H.G., Sonal G.S., Dhillon G.P. New perspectives of malaria control in India under World Bank Project. J. Indian Med. Assoc. 2009, 107(870):879-880. 882-873.
20. Das S., Shevade S., LaCount D.J., Jarori G.K. Plasmodium falciparum enolase complements yeast enolase functions and associates with the parasite food vacuole. Mol. Biochem. Parasitol. 2011, 179:8-17.
21. David P.H., Hommel M., Miller L.H., Udeinya I.J., Oligino L.D. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:5075-5079.
22. Deepa M., Alwar V.A., Rameshkumar K., Ross C. ABO blood groups and malaria related clinical outcome. J. Vector Borne Dis. 2011, 48:7-11.
23. Dey S., Guha M., Alam A., Goyal M., Bindu S., Pal C., Maity P., Mitra K., Bandyopadhyay U. Malarial infection develops mitochondrial pathology and mitochondrial oxidative stress to promote hepatocyte apoptosis. Free Radic. Biol. Med. 2009, 46:271-281.
24. Dharia N.V., Sidhu A.B., Cassera M.B., Westenberger S.J., Bopp S.E., Eastman R.T., Plouffe D., Batalov S., Park D.J., Volkman S.K., Wirth D.F., Zhou Y., Fidock D.A., Winzeler E.A. Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol. 2009, 10:R21.
25. Dhangadamajhi G., Kar S.K., Ranjit M.R. High prevalence and gender bias in distribution of Plasmodium malariae infection in central east-coast India. Trop. Biomed. 2009, 26:326-333.
26. Dhangadamajhi G., Rout B.K., Kar S.K., Ranjit M.R. Genetic diversity of Plasmodium vivax in a hyperendemic area predominated by Plasmodium falciparum; a preliminary study. Trop. Biomed. 2010, 27:578-584.
27. Dhiman S., Goswami D., Rabha B., Gopalakrishnan R., Baruah I., Singh L. Malaria epidemiology along Indo-Bangladesh border in Tripura State, India. Southeast Asian J. Trop. Med. Public Health 2010, 41:1279-1289.
28. Dhingra N., Jha P., Sharma V.P., Cohen A.A., Jotkar R.M., Rodriguez P.S., Bassani D.G., Suraweera W., Laxminarayan R., Peto R. Adult and child malaria mortality in India: a nationally representative mortality survey. Lancet 2010, 376:1768-1774.
29. Dondorp A.M., Angus B.J., Hardeman M.R., Chotivanich K.T., Silamut K., Ruangveerayuth R., Kager P.A., White N.J., Vreeken J. Prognostic significance of reduced red blood cell deformability in severe falciparum malaria. Am. J. Trop. Med. Hyg. 1997, 57:507-511.
30. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., et al. Artemisinin Resistance in Plasmodium falciparum Malaria. N. Engl. J. Med. 2009, 361:455-467.
31. Dondorp A.M., Nyanoti M., Kager P.A., Mithwani S., Vreeken J., Marsh K. The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:282-286.
32. Dondorp A.M., Yeung S., White L., Nguon C., Day N.P.J., Socheat D., von Seidlein L. Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol. 2010, 8:272-280. 2010.
33. Duffy P.E., Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 2003, 71:6620-6623.
34. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996, 272:1502-1504.
35. Fried M., Nosten F., Brockman A., Brabin B.J., Duffy P.E. Maternal antibodies block malaria. Nature 1998, 395:851-852.
36. Garg S., Saxena V., Kanchan S., Sharma P., Mahajan S., Kochar D., Das A. Novel point mutations in sulfadoxine resistance genes of Plasmodium falciparum from India. Acta Trop. 2009, 110:75-79.
37. Ganesan K., Ponmee N., Jiang L., Fowble J.W., White J., Kamchonwongpaisan S., Yuthavong Y., Wilairat P., Rathod P.K. A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates. PLoS Pathog. 2008, 4:e1000214.
38. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
39. Gaur D., Chitnis C.E. Molecular interactions and signaling mechanisms during erythrocyte invasion by malaria parasites. Curr. Opin. Microbiol. 2011, 14:422-428.
40. Gill J., Chitnis C.E., Sharma A. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria. Malar. J. 2009, 8:67.
41. Gogia S., Balaram H., Puranik M. Hypoxanthine guanine phosphoribosyl transferase distorts the purine ring of nucleotide substrates and perturbs the pKa of bound xanthosine monophosphate. Biochemistry 2011, 50:4184-4193.
42. Gupta B., Awasthi G., Das A. Malaria parasite genome scan: insights into antimalarial resistance. Parasitol. Res. 2010, 107:495-499.
43. Harris V.K., Richard V.S., Mathai E., Sitaram U., Kumar K.V., Cherian A.M., Amelia S.M., Anand G. A study on clinical profile of falciparum malaria in a tertiary care hospital in south India. Indian J. Malariol. 2001, 38:19-24.
44. Herricks T., Antia M., Rathod P.K. Deformability limits of Plasmodium falciparum-infected red blood cells. Cell. Microbiol. 2009, 11:1340-1353.
45. Herricks T., Seydel K.B., Turner G., Molyneux M., Heyderman R., Taylor T., Rathod P.K. A microfluidic system to study cytoadhesion of Plasmodium falciparum infected erythrocytes to primary brain microvascular endothelial cells. Lab Chip. 2011, 11:2994-3000.
46. ICMR-WHO Health Research Directory, 2007. http://www.whoindia.org/linkfiles/medical_ethics_directory_of_health_research_institutions.pdf.
47. Imam M., Devi Y.S., Verma A.K., Chauhan V.S. Comparative immunogenicities of full-length Plasmodium falciparum merozoite surface protein 3 and a 24-kilodalton N-terminal fragment. Clin. Vaccine Immunol. 2011, 18:1221-1228.
48. Jallow M., Teo Y.Y., Small K.S., Rockett K.A., Deloukas P., Clark T.G., Kivinen K., Bojang K.A., Conway D.J., Pinder M., Sirugo G., Sisay-Joof F., Usen S., Auburn S., Bumpstead S.J., Campino S., Coffey A., Dunham A., Fry A.E., Green A., Gwilliam R., Hunt S.E., Inouye M., Jeffreys A.E., Mendy A., Palotie A., Potter S., Ragoussis J., Rogers J., Rowlands K., Somaskantharajah E., Whittaker P., Widden C., Donnelly P., Howie B., Marchini J., Morris A., SanJoaquin M., Achidi E.A., Agbenyega T., Allen A., Amodu O., Corran P., Djimde A., Dolo A., Doumbo O.K., Drakeley C., Dunstan S., Evans J., Farrar J., Fernando D., Hien T.T., Horstmann R.D., Ibrahim M., Karunaweera N., Kokwaro G., Koram K.A., Lemnge M., Makani J., Marsh K., Michon P., Modiano D., Molyneux M.E., Mueller I., Parker M., Peshu N., Plowe C.V., Puijalon O., Reeder J., Reyburn H., Riley E.M., Sakuntabhai A., Singhasivanon P., Sirima S., Tall A., Taylor T.E., Thera M., Troye-Blomberg M., Williams T.N., Wilson M., Kwiatkowski D.P. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 2009, 41:657-665.
49. Kochar D.K., Das A., Kochar A., Middha S., Acharya J., Tanwar G.S., Gupta A., Pakalapati D., Garg S., Saxena V., Subudhi A.K., Boopathi P.A., Sirohi P., Kochar S.K. Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: a study from Bikaner (Northwestern India). Platelets 2010, 21:623-627.
50. Kochar D.K., Saxena V., Singh N., Kochar S.K., Kumar S.V., Das A. Plasmodium vivax malaria. Emerg. Infect. Dis. 2005, 11:132-134.
51. Kumar A., Chery L., et al. Malaria in South Asia: prevalence and control. Acta Trop. 2012, 121:246-255.
52. Kumar A., Dua V.K., Rathod P.K. Malaria-attributed death rates in India. Lancet 2011, 377:991-992. author reply 994-995.
53. Kumar B., Chaubey S., Shah P., Tanveer A., Charan M., Siddiqi M.I., Habib S. Interaction between sulphur mobilisation proteins SufB and SufC: evidence for an iron-sulphur cluster biogenesis pathway in the apicoplast of Plasmodium falciparum. Int. J. Parasitol. 2011, 41:991-999.
54. Kumar N., Khan S.I., Atheaya H., Mamgain R., Rawat D.S. Synthesis and in vitro antimalarial activity of tetraoxane-amine/amide conjugates. Eur. J. Med. Chem. 2011, 46:2816-2827.
55. Kumar A., Valecha N., Jain T., Dash A.P. Burden of malaria in India: retrospective and prospective view. Am. J. Trop. Med. Hyg. 2007, 77:69-78.
56. Kyriacou H.M., Stone G.N., Challis R.J., Raza A., Lyke K.E., Thera M.A., Kone A.K., Doumbo O.K., Plowe C.V., Rowe J.A. Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol. Biochem. Parasitol. 2006, 150:211-218.
57. Lakshmi V., Srivastava S., Mishra S.K., Srivastava M.N., Srivastava K., Puri S.K. Antimalarial activity in Xylocarpus granatum (Koen). Nat. Prod. Res. 2011, Epub Jul 26 2011.
58. Lumb V., Das M.K., Mittra P., Ahmed A., Kumar M., Kaur P., Dash A.P., Singh S.S., Sharma Y.D. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami. J. Infect. Dis. 2009, 199:1064-1073.
59. Lumb V., Das M.K., Singh N., Dev V., Khan W., Sharma Y.D. Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India. Antimicrob. Agents Chemother. 2011, 55:2813-2817.
60. Lumb V., Das M.K., Singh N., Dev V., Khan W., Sharma Y.D. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India. Antimicrob. Agents Chemother. 2009, 53:5173-5180.
61. Lumb V., Sharma Y.D. Novel K540N mutation in Plasmodium falciparum dihydropteroate synthetase confers a lower level of sulfa drug resistance than does a K540E mutation. Antimicrob. Agents Chemother. 2011, 55:2481-2482.
62. Mahajan R.C., Narain K., Mahanta J. Anaemia & expression levels of CD35, CD55 & CD59 on red blood cells in Plasmodium falciparum malaria patients from India. Indian J. Med. Res. 2011, 133:662-664.
63. Maity K., Venkata B.S., Kapoor N., Surolia N., Surolia A., Suguna K. Structural basis for the functional and inhibitory mechanisms of beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Plasmodium falciparum. J. Struct. Biol. 2011, 176:238-249.
64. Majumder P.P. The human genetic history of South Asia. Curr. Biol. 2010, 20(4):R184-R187.
65. Majumder P.P., Staats H.F., Sarkar-Roy N., Varma B., Ghosh T., Maiti S., Narayanasamy K., Whisnant C.C., Stephenson J.L., Wagener D.K. Genetic determinants of immune-response to a polysaccharide vaccine for typhoid. Hugo J. 2009, 3(1-4):17-30.
66. Marsh K., Otoo L., Hayes R.J., Carson D.C., Greenwood B.M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 1989, 83:293-303.
67. Mayor A., Rovira-Vallbona E., Srivastava A., Sharma S.K., Pati S.S., Puyol L., Quinto L., Bassat Q., Machevo S., Mandomando I., Chauhan V.S., Alonso P.L., Chitnis C.E. Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting. Infect. Immun. 2009, 77:3857-3863.
68. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature 2002, 415:673-679.
69. Miller L.H., Usami S., Chien S. Alteration in the rheologic properties of Plasmodium knowlesi - infected red cells. A possible mechanism for capillary obstruction. J. Clin. Invest. 1971, 50:1451-1455.
70. Mishra K., Dash A.P., Dey N. Andrographolide: a novel antimalarial diterpene lactone compound from andrographis paniculata and its interaction with Curcumin and Artesunate. J. Trop. Med. 2011, 2011:579518.
71. Mixson-Hayden T., Jain V., McCollum A.M., Poe A., Nagpal A.C., Dash A.P., Stiles J.K., Udhayakumar V., Singh N. Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India. Antimicrob. Agents Chemother. 2010, 54:997-1006.
72. Mohanty A., Swain S., Singh D.V., Mahapatra N., Kar S.K., Hazra R.K. A unique methodology for detecting the spread of chloroquine-resistant strains of Plasmodium falciparum, in previously unreported areas, by analyzing anophelines of malaria endemic zones of Orissa, India. Infect. Genet. Evol. 2009, 9:462-467.
73. Mohanty S., Saklani S., Mahajan M. In silico characterization of genetic homology in nuclear-encoded apicoplast-targeted genes between Plasmodium falciparum & P. vivax. Indian J. Med. Res. 2009, 129:520-524.
74. Mullick S., Das S., Guha S.K., Bera D.K., Sengupta S., Roy D., Saha P., Biswas A., Das M., Ray K., Kundu P.K., Maji A.K. Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India. Trop. Med. Int. Health 2011.
75. Nagaraj V.A., Arumugam R., Prasad D., Rangarajan P.N., Padmanaban G. Protoporphyrinogen IX oxidase from Plasmodium falciparum is anaerobic and is localized to the mitochondrion. Mol. Biochem. Parasitol. 2010, 174:44-52.
76. Nagaraj V.A., Prasad D., Arumugam R., Rangarajan P.N., Padmanaban G. Characterization of coproporphyrinogen III oxidase in Plasmodium falciparum cytosol. Parasitol. Int. 2010, 59:121-127.
77. O'Neil-Dunne I., Achur R.N., Agbor-Enoh S.T., Valiyaveettil M., Naik R.S., Ockenhouse C.F., Zhou A., Megnekou R., Leke R., Taylor D.W., Gowda D.C. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect. Immun. 2001, 69:7487-7492.
78. Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Hori M., Nakamura Y., Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 2002, 32:650-654.
79. Ozarkar A.D., Prakash D., Deobagkar D.N., Deobagkar D.D. Prediction of B cell and T cell epitopes of DBLalpha domain in Plasmodium falciparum malaria vaccine candidate var gene. Protein Pept. Lett. 2007, 14:528-530.
80. Palanichamy M.G., Sun C., Agrawal S., Bandelt H.J., Kong Q.P., Khan F., Wang C.Y., Chaudhuri T.K., Palla V., Zhang Y.P. Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am. J. Hum. Genet. 2004, 75:966-978.
81. Parise M.E., Lewis L.S., Ayisi J.G., Nahlen B.L., Slutsker L., Muga R., Sharif S.K., Hill J., Steketee R.W. A rapid assessment approach for public health decision-making related to the prevention of malaria during pregnancy. Bull. World Health Org. 2003, 81:316-323.
82. Parija S.C. PCR for diagnosis of malaria. Indian J. Med. Res. 2010, 132:9-10.
83. Parween S., Gupta P.K., Chauhan V.S. Induction of humoral immune response against PfMSP-1(19) and PvMSP-1(19) using gold nanoparticles along with alum. Vaccine 2011, 29:2451-2460.
84. Patial R.K., Kapoor D., Mokta J.K. Cerebral dysfunction in vivax malaria: a case report. Indian J. Med. Sci. 1998, 52:159-160.
85. Patakottu B.R., Singh P.K., Malhotra P., Chauhan V.S., Patankar S. In vivo analysis of translation initiation sites in Plasmodium falciparum. Mol. Biol. Rep. 2011.
86. Prusty D., Dar A., Priya R., Sharma A., Dana S., Choudhury N.R., Rao N.S., Dhar S.K. Single-stranded DNA binding protein from human malarial parasite Plasmodium falciparum is encoded in the nucleus and targeted to the apicoplast. Nucleic Acids Res. 2010, 38:7037-7053.
87. Prajapati S.K., Joshi H., Dev V., Dua V.K. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India. Malar. J. 2011, 10:102.
88. Rajesh V., Elamaran M., Vidya S., Gowrishankar M., Kochar D., Das A. Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. Exp. Parasitol. 2007, 116:252-256.
89. Ranjan R., Chugh M., Kumar S., Singh S., Kanodia S., Hossain M.J., Korde R., Grover A., Dhawan S., Chauhan V.S., Reddy V.S., Mohmmed A., Malhotra P. Proteome analysis reveals a large merozoite surface protein-1 associated complex on the Plasmodium falciparum merozoite surface. J. Proteome Res. 2011, 10:680-691.
90. Rawat M., Vijay S., Gupta Y., Dixit R., Tiwari P.K., Sharma A. Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates. Infect. Genet. Evol. 2011, 11:924-933.
91. Rout R., Dhangadamajhi G., Mohapatra B.N., Kar S.K., Ranjit M. High CR1 level and related polymorphic variants are associated with cerebral malaria in eastern-India. Infect. Genet. Evol. 2011, 11:139-144.
92. Rout R., Mohapatra B.N., Kar S.K., Ranjit M. Genetic complexity and transmissibility of Plasmodium falciparum parasites causing severe malaria in central-east coast India. Trop. Biomed. 2009, 26:165-172.
93. Rao M. The international centres of excellence for malaria research. Acta Trop. 2012, 121:157.
94. Rao T.R. The Anophilines of India 1983, Malaria Research Centre, Indian Council of Medical Research.
95. Rathod P.K., Khosla M., Gassis S., Young R.D., Lutz C. Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 1994, 38:2871-2876.
96. Rathod P.K., McErlean T., Lee P.C. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9389-9393.
97. Richards J.B., Rivadeneira F., Inouye M., Pastinen T.M., Soranzo N., Wilson S.G., Andrew T., Falchi M., Gwilliam R., Ahmadi K.R., Valdes A.M., Arp P., Whittaker P., Verlaan D.J., Jhamai M., Kumanduri V., Moorhouse M., van Meurs J.B., Hofman A., Pols H.A., Hart D., Zhai G., Kato B.S., Mullin B.H., Zhang F., Deloukas P., Uitterlinden A.G., Spector T.D. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008, 371:1505-1512.
98. Roper C., Pearce R., Nair S., Sharp B., Nosten F., Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004, 305:1124.
99. Sahar T., Reddy K.S., Bharadwaj M., Pandey A.K., Singh S., Chitnis C.E., Gaur D. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 2011, 6:e17102.
100. Sarkar S., Biswas N.K., Dey B., Mukhopadhyay D., Majumder P.P. A large, systematic molecular-genetic study of G6PD in Indian populations identifies a new non-synonymous variant and supports recent positive selection. Infect. Genet. Evol. 2010, 10:1228-1236.
101. Schnitzer B., Sodeman T., Mead M.L., Contacos P.G. Pitting function of the spleen in malaria: ultrastructural observations. Science 1972, 177:175-177.
102. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., Prokunina-Olsson L., Ding C.J., Swift A.J., Narisu N., Hu T., Pruim R., Xiao R., Li X.Y., Conneely K.N., Riebow N.L., Sprau A.G., Tong M., White P.P., Hetrick K.N., Barnhart M.W., Bark C.W., Goldstein J.L., Watkins L., Xiang F., Saramies J., Buchanan T.A., Watanabe R.M., Valle T.T., Kinnunen L., Abecasis G.R., Pugh E.W., Doheny K.F., Bergman R.N., Tuomilehto J., Collins F.S., Boehnke M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
103. Shah N.K., Dhillon G.P., Dash A.P., Arora U., Meshnick S.R., Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect. Dis. 2011, 11:57-64.
104. Sharma V.P. Hidden burden of malaria in Indian women. Malar. J. 2009, 8:281.
105. Singh N. A new global malaria eradication strategy: implications for malaria research from an Indian perspective. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:1202-1203.
106. Singh N., Shukla M.M., Chand G., Bharti P.K., Singh M.P., Shukla M.K., Mehra R.K., Sharma R.K., Dash A.P. Epidemic of Plasmodium falciparum malaria in Central India, an area where chloroquine has been replaced by artemisinin-based combination therapy. Trans. R. Soc. Trop. Med. Hyg. 2011, 105:133-139.
107. Singh N., Shukla M.M., Shukla M.K., Mehra R.K., Sharma S., Bharti P.K., Singh M.P., Singh A., Gunasekar A. Field and laboratory comparative evaluation of rapid malaria diagnostic tests versus traditional and molecular techniques in India. Malar. J. 2010, 9:191.
108. Singh S., Alam M.M., Pal-Bhowmick I., Brzostowski J.A., Chitnis C.E. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 2010, 6:e1000746.
109. Sharma M.K., Agarwal G.S., Rao V.K., Upadhyay S., Merwyn S., Gopalan N., Rai G.P., Vijayaraghavan R., Prakash S. Amperometric immunosensor based on gold nanoparticles/alumina sol-gel modified screen-printed electrodes for antibodies to Plasmodium falciparum histidine rich protein-2. Analyst 2010, 135:608-614.
110. Sharma M.K., Rao V.K., Merwyn S., Agarwal G.S., Upadhyay S., Vijayaraghavan R. A novel piezoelectric immunosensor for the detection of malarial Plasmodium falciparum histidine rich protein-2 antigen. Talanta 2011, 85:1812-1817.
111. Sharma S.K., Chattopadhyay R., Chakrabarti K., Pati S.S., Srivastava V.K., Tyagi P.K., Mahanty S., Misra S.K., Adak T., Das B.S., Chitnis C.E. Epidemiology of malaria transmission and development of natural immunity in a malaria-endemic village, San Dulakudar, in Orissa state, India. Am. J. Trop. Med. Hyg. 2004, 71:457-465.
112. Sharma S.K., Tyagi P.K., Padhan K., Upadhyay A.K., Haque M.A., Nanda N., Joshi H., Biswas S., Adak T., Das B.S., Chauhan V.S., Chitnis C.E., Subbarao S.K. Epidemiology of malaria transmission in forest and plain ecotype villages in Sundargarh District, Orissa, India. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:917-925.
113. Sharma V.P. Forest malaria in South East Asia 1991, Malaria Research Centre, New Delhi.
114. Shukla R.P., Pandey A.C., Mathur A. Investigations of malaria outbreak in Rajasthan. Indian J. Malariol. 1995, 32.
115. Singh N., Shukla M.M., Sharma V.P. Epidemiology of malaria in pregnancy in central India. Bull. World Health Org. 1999, 77:567-572.
116. Singh S.K., Hora R., Belrhali H., Chitnis C.E., Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 2006, 439:741-744.
117. Singh V., Mishra N., Awasthi G., Dash A.P., Das A. Why is it important to study malaria epidemiology in India?. Trends Parasitol. 2009, 25:452-457.
118. Sinton J.A. What Malaria Costs India 1936, Government Press of India Press, Delhi.
119. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
120. Tanwar G.S., Khatri P.C., Sengar G.S., Kochar A., Kochar S.K., Middha S., Tanwar G., Khatri N., Pakalapati D., Garg S., Das A., Kochar D.K. Clinical profiles of 13 children with Plasmodium vivax cerebral malaria. Ann. Trop. Paediatr. 2011, 31:351-356.
121. Trimnell A.R., Kraemer S.M., Mukherjee S., Phippard D.J., Janes J.H., Flamoe E., Su X.Z., Awadalla P., Smith J.D. Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. Mol. Biochem. Parasitol. 2006, 148:169-180.
122. Vaid A., Ranjan R., Smythe W.A., Hoppe H.C., Sharma P. PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum, is exported to the host erythrocyte and is involved in hemoglobin trafficking. Blood 2010, 115:2500-2507.
123. Valecha N., Bagga A., Chandra J., Sharma D. Cerebral symptoms with P. vivax malaria. Indian Pediatr. 1992, 29:1176-1178.
124. Valecha N., Joshi H., Eapen A., Ravinderan J., Kumar A., Prajapati S.K., Ringwald P. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:831-837.
125. Valecha N., Joshi H., Mallick P.K., Sharma S.K., Kumar A., Tyagi P.K., Shahi B., Das M.K., Nagpal B.N., Dash A.P. Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India. Acta Trop. 2009, 111:21-28.
126. Valecha N., Looareesuwan S., Martensson A., Abdulla S.M., Krudsood S., Tangpukdee N., Mohanty S., Mishra S.K., Tyagi P.K., Sharma S.K., Moehrle J., Gautam A., Roy A., Paliwal J.K., Kothari M., Saha N., Dash A.P., Bjorkman A. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial. Clin. Infect. Dis. 2010, 51:684-691.
127. Valecha N., Phyo A.P., Mayxay M., Newton P.N., Krudsood S., Keomany S., Khanthavong M., Pongvongsa T., Ruangveerayuth R., Uthaisil C., Ubben D., Duparc S., Bacchieri A., Corsi M., Rao B.H., Bhattacharya P.C., Dubhashi N., Ghosh S.K., Dev V., Kumar A., Pukrittayakamee S. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS One 2010, 5:e11880.
128. Valecha N., Pinto R.G., Turner G.D., Kumar A., Rodrigues S., Dubhashi N.G., Rodrigues E., Banaulikar S.S., Singh R., Dash A.P., Baird J.K. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2009, 81:758-762.
129. WHO, 2009. Global malaria control and elimination: report of a technical review.
130. Williams T.N., Mwangi T.W., Roberts D.J., Alexander N.D., Weatherall D.J., Wambua S., Kortok M., Snow R.W., Marsh K. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2005, 2:e128.
131. Wootton J.C., Feng X., Ferdig M.T., Cooper R.A., Mu J., Baruch D.I., Magill A.J., Su X.Z. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.